Acadia Pharmaceuticals

Acadia Pharmaceuticals

Develops treatments for neuro-psychiatric disorders

About Acadia Pharmaceuticals

Simplify's Rating
Why Acadia Pharmaceuticals is rated
B-
Rated C on Competitive Edge
Rated B on Growth Potential
Rated B on Differentiation

Industries

Biotechnology

Healthcare

Company Size

501-1,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1993

Overview

Acadia Pharmaceuticals focuses on developing and providing treatments for patients with serious neurological and psychiatric conditions. The company has created the first FDA-approved medication specifically for managing hallucinations and delusions related to Parkinson’s disease psychosis, as well as the first approved treatment for Rett syndrome in the U.S. and Canada. Their products work by targeting the underlying symptoms of these conditions, helping to improve the quality of life for patients. What sets Acadia apart from its competitors is its commitment to addressing rare and complex neuro-psychiatric disorders, with ongoing research aimed at developing therapies for conditions like Prader-Willi syndrome and Alzheimer’s disease psychosis. The goal of Acadia Pharmaceuticals is to provide effective solutions that enhance the well-being of patients and their families.

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's DAYBUE is now available for treating Rett syndrome in the U.S.
  • The company benefits from increased focus on rare diseases and orphan drug incentives.
  • Successful public offering indicates strong investor confidence and capital for R&D.

What critics are saying

  • Increased competition in CNS disorder treatments, including RNA-based therapies.
  • Class action lawsuit could lead to financial and reputational damage.
  • Potential over-reliance on partnerships like the one with Neuren Pharmaceuticals.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with innovative small molecule drugs.
  • The company launched a documentary series to raise awareness for Rett syndrome.
  • Acadia collaborates with Stoke Therapeutics on RNA-based therapies for Rett syndrome.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$779.8M

Above

Industry Average

Funded Over

5 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

0%
Endpoints News
May 30th, 2025
Another Bristol Myers exec goes to Acadia; David Southwell takes CEO job at ARCH-backed cancer biotech

Allyson McMillan-Youngblood has left Bristol Myers Squibb to join Acadia Pharmaceuticals as SVP of its rare disease franchise.

ETF Daily News
Mar 27th, 2025
Cibc World Markets Corp Invests $206,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Cibc World Markets Corp invests $206,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

Recently Posted Jobs

Sign up to get curated job recommendations

Acadia Pharmaceuticals is Hiring for 32 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →